Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Lakehead University

$22,000.00

Modulation of Innate Immune Responses: Synthesis and Biological Studies of Homo- and Hetero-dimeric Pattern Recognition Receptor Agonists and Other Immunostimulants

FY 2018-19

Summary
Immune cells defend against microbial infection by detecting pathogen-associated molecular patterns (PAMPs) present on microbes via pattern recognition receptors. Harnessing signalling by targeting these receptors with small molecule immunostimulants could greatly benefit the development of effective therapeutic agents. Although a good number of immunostimulants are known to date, the translation of these molecules into clinical uses is challenging for a number of reasons, such as: (a) a lack of understanding of the exact mechanisms of their action, and thus the inability to precisely predict effects, (b) relatively low potency of some immunostimulants, and (c) toxic side effects of others. In this research, we propose to covalently link different immunostimulants in order to study the effects of particular combinations of such molecules on their immunological properties. Covalently linked dimeric ligands containing two immunostimulants can simultaneously target two receptors of the immune system. Such dimeric ligands thereby become more potent immune activating agents due to a synergistic effect between the two immunostimulants. A group of dimeric ligands comprised of several different types of immunostimulants and different lengths of linking spacers will be chemically synthesized. Biological studies using in vitro experiments will reveal the immunostimulatory activity of these compounds. This research will provide useful tools for binding immunostimulating molecules to study innate immune response to synthetic immunostimulants and the crosstalk mechanisms between receptors. Through chemical synthesis and biological studies, more potent immunostimulants with no toxic side effects will be discovered. The long term goal of this research is to discover novel immunostimulatory agents with high potency and defined immunological effects, which will provide useful molecular tools for health-related research and ultimately lead to the development of clinically useful therapeutic agents such as vaccine adjuvants.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2017-05363
Name nom
Jiang, ZiHua
Department département
Chemistry
Organization id
25
Institution établissement
Lakehead University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2017
Award amount
22000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3703
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic syntheses
Research subject fr
Synthèses organiques
Partie
2
Nb partie
5
Application title
Modulation of Innate Immune Responses: Synthesis and Biological Studies of Homo- and Hetero-dimeric Pattern Recognition Receptor Agonists and Other Immunostimulants
Keyword
NSERC
Application summary
Immune cells defend against microbial infection by detecting pathogen-associated molecular patterns (PAMPs) present on microbes via pattern recognition receptors. Harnessing signalling by targeting these receptors with small molecule immunostimulants could greatly benefit the development of effective therapeutic agents. Although a good number of immunostimulants are known to date, the translation of these molecules into clinical uses is challenging for a number of reasons, such as: (a) a lack of understanding of the exact mechanisms of their action, and thus the inability to precisely predict effects, (b) relatively low potency of some immunostimulants, and (c) toxic side effects of others. In this research, we propose to covalently link different immunostimulants in order to study the effects of particular combinations of such molecules on their immunological properties. Covalently linked dimeric ligands containing two immunostimulants can simultaneously target two receptors of the immune system. Such dimeric ligands thereby become more potent immune activating agents due to a synergistic effect between the two immunostimulants. A group of dimeric ligands comprised of several different types of immunostimulants and different lengths of linking spacers will be chemically synthesized. Biological studies using in vitro experiments will reveal the immunostimulatory activity of these compounds. This research will provide useful tools for binding immunostimulating molecules to study innate immune response to synthetic immunostimulants and the crosstalk mechanisms between receptors. Through chemical synthesis and biological studies, more potent immunostimulants with no toxic side effects will be discovered. The long term goal of this research is to discover novel immunostimulatory agents with high potency and defined immunological effects, which will provide useful molecular tools for health-related research and ultimately lead to the development of clinically useful therapeutic agents such as vaccine adjuvants.
Lakehead University - $22,000 Grant (2018-19) | Canada Spends